305 related articles for article (PubMed ID: 32240714)
21. A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors.
Dubbink HJ; Hollink IHIM; Avenca Valente C; Wang W; Liu P; Doukas M; van Noesel MM; Dinjens WNM; Wagner A; Smits R
Pediatr Blood Cancer; 2018 Jun; 65(6):e26991. PubMed ID: 29446530
[TBL] [Abstract][Full Text] [Related]
22. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.
Matsumoto S; Yamamichi T; Shinzawa K; Kasahara Y; Nojima S; Kodama T; Obika S; Takehara T; Morii E; Okuyama H; Kikuchi A
Nat Commun; 2019 Aug; 10(1):3882. PubMed ID: 31462641
[TBL] [Abstract][Full Text] [Related]
23. Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
Abril-Fornaguera J; Torrens L; Andreu-Oller C; Carrillo-Reixach J; Rialdi A; Balaseviciute U; Pinyol R; Montironi C; Haber PK; Del Río-Álvarez Á; Domingo-Sàbat M; Royo L; Akers NK; Willoughby CE; Peix J; Torres-Martin M; Puigvehi M; Cairo S; Childs M; Maibach R; Alaggio R; Czauderna P; Morland B; Losic B; Mazzaferro V; Guccione E; Sia D; Armengol C; Llovet JM
Mol Cancer Ther; 2023 Apr; 22(4):485-498. PubMed ID: 36780225
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma.
Sugawara W; Haruta M; Sasaki F; Watanabe N; Tsunematsu Y; Kikuta A; Kaneko Y
Pediatr Blood Cancer; 2007 Sep; 49(3):240-9. PubMed ID: 16937357
[TBL] [Abstract][Full Text] [Related]
25. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation as a key epigenetic player for hepatoblastoma characterization.
Rivas M; Aguiar T; Fernandes G; Lemes R; Caires-Júnior L; Goulart E; Telles-Silva K; Maschietto M; Cypriano M; de Toledo S; Carraro D; da Cunha I; da Costa C; Rosenberg C; Krepischi A
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101684. PubMed ID: 33852955
[TBL] [Abstract][Full Text] [Related]
27. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.
Jia D; Dong R; Jing Y; Xu D; Wang Q; Chen L; Li Q; Huang Y; Zhang Y; Zhang Z; Liu L; Zheng S; Xia Q; Wang H; Dong K; He X
Hepatology; 2014 Nov; 60(5):1686-96. PubMed ID: 24912477
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma.
Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S
Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors.
Wirths O; Waha A; Weggen S; Schirmacher P; Kühne T; Goodyer CG; Albrecht S; Von Schweinitz D; Pietsch T
Lab Invest; 2003 Mar; 83(3):429-34. PubMed ID: 12649343
[TBL] [Abstract][Full Text] [Related]
30. Multifocal hepatic neoplasia in 3 children with APC gene mutation.
Gupta A; Sheridan RM; Towbin A; Geller JI; Tiao G; Bove KE
Am J Surg Pathol; 2013 Jul; 37(7):1058-66. PubMed ID: 23715166
[TBL] [Abstract][Full Text] [Related]
31. Activation of Wnt and Myc signaling in hepatoblastoma.
Cairo S; Armengol C; Buendia MA
Front Biosci (Elite Ed); 2012 Jan; 4(1):480-6. PubMed ID: 22201888
[TBL] [Abstract][Full Text] [Related]
32. Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.
Liu Y; Song J; Liu Y; Zhou Z; Wang X
J Exp Clin Cancer Res; 2020 Jun; 39(1):101. PubMed ID: 32493490
[TBL] [Abstract][Full Text] [Related]
33. Upregulated YAP promotes oncogenic CTNNB1 expression contributing to molecular pathology of hepatoblastoma.
Lu S; Jiang M; Chen Q; Luo X; Cao Z; Huang H; Zheng M; Du J
Pediatr Blood Cancer; 2022 Sep; 69(9):e29705. PubMed ID: 35404538
[TBL] [Abstract][Full Text] [Related]
34. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
Zhou S; Parham DM; Yung E; Pattengale P; Wang L
Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
[TBL] [Abstract][Full Text] [Related]
35. Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates.
Honda S; Minato M; Suzuki H; Fujiyoshi M; Miyagi H; Haruta M; Kaneko Y; Hatanaka KC; Hiyama E; Kamijo T; Okada T; Taketomi A
Cancer Sci; 2016 Jun; 107(6):812-9. PubMed ID: 26991471
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of molecular genetic alterations in hepatoblastoma.
von Schweinitz D; Kraus JA; Albrecht S; Koch A; Fuchs J; Pietsch T
Med Pediatr Oncol; 2002 Feb; 38(2):104-8. PubMed ID: 11813174
[TBL] [Abstract][Full Text] [Related]
37. The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.
Honda S; Haruta M; Sugawara W; Sasaki F; Ohira M; Matsunaga T; Yamaoka H; Horie H; Ohnuma N; Nakagawara A; Hiyama E; Todo S; Kaneko Y
Int J Cancer; 2008 Sep; 123(5):1117-25. PubMed ID: 18537155
[TBL] [Abstract][Full Text] [Related]
38. Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.
Pire A; Hirsch TZ; Morcrette G; Imbeaud S; Gupta B; Pilet J; Cornet M; Fabre M; Guettier C; Branchereau S; Brugières L; Guerin F; Laithier V; Coze C; Nagae G; Hiyama E; Laurent-Puig P; Rebouissou S; Sarnacki S; Chardot C; Capito C; Faure-Conter C; Aerts I; Taque S; Fresneau B; Zucman-Rossi J
Eur J Cancer; 2024 Mar; 200():113583. PubMed ID: 38330765
[TBL] [Abstract][Full Text] [Related]
39. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
Weber RG; Pietsch T; von Schweinitz D; Lichter P
Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
[TBL] [Abstract][Full Text] [Related]
40. The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.
Zhang S; Zhang J; Evert K; Li X; Liu P; Kiss A; Schaff Z; Ament C; Zhang Y; Serra M; Evert M; Chen N; Xu F; Chen X; Tao J; Calvisi DF; Cigliano A
Am J Pathol; 2020 Jul; 190(7):1397-1413. PubMed ID: 32283103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
